We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current QNCX market cap is 74.99M. The company's latest EPS is USD -0.7252 and P/E is -2.33.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -5.58M | -6.16M | -9.92M | -11.22M | -28.19M |
Net Income | -4.89M | -5.35M | -8.89M | -11.15M | -27.73M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -39.17M | -78.89M | -90.32M | -52.02M | -34.62M |
Net Income | -36.98M | -76.85M | -89.95M | -51.66M | -31.39M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 88.84M | 85.39M | 167.9M | 159.29M | 134.83M |
Total Liabilities | 1.95M | 2.25M | 82.82M | 85.12M | 87.86M |
Total Equity | 86.88M | 83.13M | 85.08M | 74.18M | 46.97M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 124.37M | 189.47M | 133.23M | 103.91M | 167.9M |
Total Liabilities | 8.89M | 17.2M | 14.64M | 3.32M | 82.82M |
Total Equity | 115.48M | 172.26M | 118.59M | 100.59M | 85.08M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -7.4M | -12.21M | -18.29M | -8.35M | -17.09M |
Investing | -14.78M | -11.15M | -5.76M | 8.91M | 3.94M |
Financing | 76k | 86k | 143k | 190k | 225k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -33.28M | -50.82M | -62.93M | -44.04M | -18.29M |
Investing | -17.75M | -52.43M | 58.95M | 18M | -5.76M |
Financing | 77.37M | 118.88M | 6.81M | 707k | 143k |
Market Cap | 74.99M |
Price to Earnings Ratio | -2.33 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 3.52 |
Price to Book Ratio | 0.86 |
Dividend Yield | - |
Shares Outstanding | 43.28M |
Average Volume (1 week) | 335.69k |
Average Volume (1 Month) | 1.3M |
52 Week Change | 86.32% |
52 Week High | 1.79 |
52 Week Low | 0.5116 |
Spread (Intraday) | 0.16 (9.2%) |
Company Name | Quince Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://quincetx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions